CRBU
Price
$1.09
Change
+$0.09 (+8.91%)
Updated
May 22 closing price
Capitalization
101.84M
81 days until earnings call
CRSP
Price
$37.53
Change
+$0.54 (+1.46%)
Updated
May 22 closing price
Capitalization
3.24B
80 days until earnings call
Interact to see
Advertisement

CRBU vs CRSP

Header iconCRBU vs CRSP Comparison
Open Charts CRBU vs CRSPBanner chart's image
Caribou Biosciences
Price$1.09
Change+$0.09 (+8.91%)
Volume$567.36K
Capitalization101.84M
CRISPR Therapeutics AG
Price$37.53
Change+$0.54 (+1.46%)
Volume$1.34M
Capitalization3.24B
CRBU vs CRSP Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. CRSP commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Buy and CRSP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CRBU: $1.10 vs. CRSP: $37.53)
Brand notoriety: CRBU and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 54% vs. CRSP: 63%
Market capitalization -- CRBU: $101.84M vs. CRSP: $3.24B
CRBU [@Biotechnology] is valued at $101.84M. CRSP’s [@Biotechnology] market capitalization is $3.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 4 bearish.
  • CRSP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than CRSP.

Price Growth

CRBU (@Biotechnology) experienced а +30.37% price change this week, while CRSP (@Biotechnology) price change was +3.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.24B) has a higher market cap than CRBU($102M). CRSP YTD gains are higher at: -4.649 vs. CRBU (-31.132). CRBU has higher annual earnings (EBITDA): -159.14M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. CRBU (208M). CRBU has less debt than CRSP: CRBU (26.2M) vs CRSP (219M). CRSP has higher revenues than CRBU: CRSP (35M) vs CRBU (9.92M).
CRBUCRSPCRBU / CRSP
Capitalization102M3.24B3%
EBITDA-159.14M-455.24M35%
Gain YTD-31.132-4.649670%
P/E RatioN/AN/A-
Revenue9.92M35M28%
Total Cash208M1.86B11%
Total Debt26.2M219M12%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUCRSP
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 5 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNECY6.010.07
+1.18%
Renesas Electronics Corp
HTHIY26.05-0.31
-1.18%
Hitachi Ltd.
JPXGY10.61-0.17
-1.62%
Japan Exchange Group, Inc.
IVFH1.42-0.07
-4.70%
Innovative Food Holdings, Inc.
DYLLF0.74-0.05
-6.01%
Deep Yellow Ltd.

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CCCC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+7.88%
CCCC - CRBU
55%
Loosely correlated
N/A
FATE - CRBU
54%
Loosely correlated
+2.56%
CRSP - CRBU
54%
Loosely correlated
+1.46%
AXON - CRBU
50%
Loosely correlated
N/A
BEAM - CRBU
50%
Loosely correlated
N/A
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+1.46%
RXRX - CRSP
72%
Closely correlated
N/A
BEAM - CRSP
71%
Closely correlated
N/A
NTLA - CRSP
69%
Closely correlated
+2.83%
PRME - CRSP
62%
Loosely correlated
N/A
ABCL - CRSP
62%
Loosely correlated
N/A
More